Specialists announced a long time ago that the artificial intelligence would forever change the future of healthcare and China is giving proof of it.
He Asian country is developing a drug with the help of generative AI and is currently in phase 2 of clinical trials. At this stage, 60 people residing in China and the United States will be treated with the medication to assess its safety, tolerability and preliminary efficacy.
He medicine called INS018:055 is developed by Insilico Medicine, a biotechnology company seeking to treat idiopathic pulmonary fibrosis (IPF).
According to Globovisión, the drug has already been administered to a human being and had a successful result. However, the medication that is administered orally must go through different phases of testing to reach the market and guarantee efficacy and safety for patients.
How did they include artificial intelligence in the development of the drug?
But how did they include artificial intelligence in the development? Taking into account that AI is capable of processing large amounts of data to provide objective information, essential for the production of new medicinesInSilico researchers took advantage of it to come up with a new molecule that can combat chronic lung disease.
As he explained in an interview with the news channel Fox and cited in Globovisión the company’s CEO Alex Zhavoronkov: “AI allows us to analyze massive amounts of data and find connections that human scientists might miss and then imagine entirely new molecules that can be turned into drugs.”
Finally, Zhavoronkov mentioned that if phase 2 is successful, the drug will go to phase 3 in which the drug will be administered to a greater number of people.
The AI has been used for more than a decade throughout the process of design, manufacture and distribution of molecules in the pharmaceutical industry, according to Live Science.
This is because, in the early stages of the investigation, the technology streamlines drug discovery because it can select from a large number of potential molecules those that should be further explored.
“While these technologies do not replace the human element, the IA along with human knowledge and interpretation, will likely help ensure more accurate results by elucidating the targets of new drugs, better understanding how a disease develops in the body over time, and helping to ensure that drugs are developed to intervene at the optimal time and in ways that are potentially meaningful to those living with a specific condition ”, the article states.
Will this be the beginning for a more effective and rapid production of drugs to combat different diseases?